Clinical Trial: A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07013201) titled 'A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis' on June 02.

Brief Summary: The main objective of the study is to evaluate the efficacy of twice daily applications of delgocitinib cream 20 mg/g compared with cream vehicle in the treatment of adult participants with mild to severe palmoplantar pustulosis (PPP). Total study duration for each participants will be approximately 18 weeks, for an approximate total of 9 visits.

Study Start Date: June 16

Study Type: INTERVENTIONAL

Condition: Palmoplantar Pustulosis

Intervention: DRUG...